Skip to main content
FDA Updates
FDA Approved Fyarro for Malignant Perivascular Epithelioid-Cell Tumor
Read More
FDA Updates
Oral Scemblix FDA Approved for Patients with Ph-Positive Chronic Myeloid Leukemia
Read More
FDA Updates
Darzalex Faspro, Kyprolis, and Dexamethasone a New Combination FDA Approved for Multiple Myeloma
Read More
FDA Updates
Keytruda Now FDA Approved for Adjuvant Treatment of Renal-Cell Carcinoma
Read More
FDA Updates
Tecentriq First Immunotherapy FDA Approved for Adjuvant Treatment of Early-Stage Non–Small-Cell Lung Cancer
Read More
FDA Updates
Keytruda plus Chemotherapy FDA Approved for First-Line Treatment of Cervical Cancer
Read More
FDA Updates
Verzenio with Endocrine Therapy FDA Approved for Adjuvant Treatment of Early Breast Cancer
Read More
FDA Updates
Tecartus FDA Approved for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Impact of Telehealth on Cancer Care
Read More
Meeting Highlights Online First
AVBCC 2021 Highlights
The Oncology Pipeline Overview: Recent Approvals and Near-Term Drugs
Read More
Page 78 of 199
Results 771 - 780 of 1986